PHIO’s latest rating updates from top analysts.
In a filing, Phio Pharmaceuticals Corp revealed its President & CEO Bitterman Robert J acquired Company’s shares for reported $2275.0 on Feb 26 ’24. In the deal valued at $0.91 per share,2,500 shares were bought. As a result of this transaction, Bitterman Robert J now holds 18,990 shares worth roughly $15761.699999999999. Then, Bitterman Robert J […]
Rise in PHIO’s short interest indicates Bearish sentiment
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Phio Pharmaceuticals Corp shares valued at $2,275 were purchased by Bitterman Robert J on Feb 26 ’24. At $0.91 per share, Bitterman Robert J acquired 2,500 shares. The insider’s holdings grew to 18,990 shares […]
